speb/financial-data huggingface dataset:
Financial ratios for JCAP — annual report dated 2025-12-31
Total revenue: 613289000
Gross profit: 449144000
Operating income: 216935000
Net income: 187965000
Capital expenditures: 1085000
Operating cash flow: 268813000
Depreciation & amortization: 5254000
Net tangible assets: 411580000
Owner earnings: 192134000
Return on net tangible assets (%): 46.68205452159969
Capex to operating income (%): 0.5001498144605527
Buffett classification: The Great
Stock price: 21.76
P/E ratio: 7.132771252520417
Shares outstanding: 61613573
Book value: 476135000
P/B ratio: 2.8158218750564443
Market cap (USD): 1340711348.48
Debt to equity: 2.9593287618007498
Current ratio: 6.118932875930498
Quick ratio: 6.118932875930498
Effective tax rate (%): 13.94962368840301
COGS to revenue (%): 26.76470636192725
SG&A to revenue (%): 24.033530684554915
Free cash flow (dilution-adjusted): 250504000
Buyback yield (%): 0
Retained earnings: 522632000
Receivables turnover: 0.3133343449314591
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.327771482605815
FCF margin (%): 40.84599593340171
Revenue growth (%): 41.52572685252492
Rule of 40 score: 82.37172278592664
Financial ratios for JGCHEM.NS — annual report dated 2024-03-31
Total revenue: 80066075.06895311
Gross profit: 13313466.842547068
Operating income: 4945796.858136467
Net income: 3850341.7675980334
Capital expenditures: 1132270.056361674
Operating cash flow: 9109485.54982612
Depreciation & amortization: 542750.9293680297
Net tangible assets: 47772514.69001079
Owner earnings: 3260822.640604389
Return on net tangible assets (%): 6.825729526200187
Capex to operating income (%): 22.893581941177903
Buffett classification: The Great
Stock price: 2.0621401151631478
P/E ratio: 20.987007737243143
Shares outstanding: 39186063
Book value: 48627893.03273774
P/B ratio: 1.6617448840156122
Market cap (USD): 80807152.46761036
Debt to equity: 0.03397466881047969
Current ratio: 9.98395518604887
Quick ratio: 8.573253573963298
Effective tax rate (%): 25.50693703308431
Interest coverage ratio: 12.4375753920386
COGS to revenue (%): 83.37190023230005
SG&A to revenue (%): 2.0098222028514043
Free cash flow (dilution-adjusted): 7975776.471999041
Buyback yield (%): 0
Retained earnings: 24146060.678738456
Inventory turnover: 10.001796783757076
Receivables turnover: 5.72184800493624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.070812883061068
FCF margin (%): 9.961493010779261
Revenue growth (%): -16.214288368890138
Rule of 40 score: -6.252795358110877
Financial ratios for JGCHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 52106067.84519828
Buffett classification: The Gruesome
Stock price: 4.760272336359293
Shares outstanding: 39186063
Book value: 53118251.31390349
P/B ratio: 3.511718233482346
Market cap (USD): 186536331.66973245
Debt to equity: 0.02895396059419032
Current ratio: 13.559923142056926
Quick ratio: 11.458216635185305
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JGCHEM.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.684462058514978
Shares outstanding: 39186063
Market cap (USD): 183565625.3460776
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JGCHEM.NS — quarterly report dated 2025-03-31
Total revenue: 26216273.088613514
Gross profit: 4646714.987140519
Operating income: 2117371.9897124153
Net income: 1859480.9445873275
Capital expenditures: 0
Net tangible assets: 54329904.13841477
Owner earnings: 1859480.9445873275
Return on net tangible assets (%): 3.4225735790918757
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.4962072587233046
P/E ratio: 18.41946784937255
Shares outstanding: 39186063
Book value: 55484334.81412204
P/B ratio: 2.4692122264844816
Market cap (USD): 137002597.9013887
Debt to equity: 0.00042139595839136304
Current ratio: 19.90496682804375
Quick ratio: 14.909270216962526
Effective tax rate (%): 26.192464736451377
Interest coverage ratio: 190.6526315789474
COGS to revenue (%): 82.2754555102696
Buyback yield (%): 0
Retained earnings: 31022796.352583583
Inventory turnover: 1.655593840852805
Receivables turnover: 1.580901220990892
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.808066069273499
Rule of 40 score: 0
Financial ratios for JGCHEM.NS — annual report dated 2025-03-31
Total revenue: 99128361.00070141
Gross profit: 19724105.68155249
Operating income: 9438157.587093757
Net income: 7804418.9852700485
Capital expenditures: 536357.2597615151
Operating cash flow: -1308978.2557867663
Depreciation & amortization: 629062.4269347673
Net tangible assets: 54329904.13841477
Owner earnings: 7897124.1524433
Return on net tangible assets (%): 14.535501723551764
Capex to operating income (%): 5.682859761686526
Buffett classification: The Great
Stock price: 3.4962072587233046
P/E ratio: 17.554490367568107
Shares outstanding: 39186063
Book value: 55484334.81412204
P/B ratio: 2.4692122264844816
Market cap (USD): 137002597.9013887
Debt to equity: 0.00042139595839136304
Current ratio: 19.90496682804375
Quick ratio: 14.909270216962526
Effective tax rate (%): 25.739710789766406
Interest coverage ratio: 95.31759149940969
COGS to revenue (%): 80.10245959638844
SG&A to revenue (%): 1.8937571349051354
Free cash flow (dilution-adjusted): -1857259.7615150805
Buyback yield (%): 0
Retained earnings: 31022796.352583583
Inventory turnover: 6.094756110692366
Receivables turnover: 5.977666864055494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.97440404354719
FCF margin (%): -1.873590708820394
Revenue growth (%): 23.808193314499068
Rule of 40 score: 21.934602605678673
Financial ratios for JGCHEM.NS — quarterly report dated 2025-06-30
Total revenue: 25910484.437163588
Gross profit: 4855487.947577815
Operating income: 2569272.174116546
Net income: 1914228.879007723
Capital expenditures: 0
Owner earnings: 1914228.879007723
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.729347062953429
P/E ratio: 49.109364689097205
Shares outstanding: 39186063
Market cap (USD): 185324491.95775804
Effective tax rate (%): 25.11787594415198
Interest coverage ratio: 197.8108108108108
COGS to revenue (%): 81.26052811033685
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.1664077896058347
Rule of 40 score: -1.1664077896058347
Financial ratios for JGCHEM.NS — quarterly report dated 2025-09-30
Total revenue: 24833934.61104848
Gross profit: 4250056.369785795
Operating income: 1877339.3461104848
Net income: 1694701.2401352874
Capital expenditures: 0
Net tangible assets: 55596279.59413754
Owner earnings: 1694701.2401352874
Return on net tangible assets (%): 3.048227781619381
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.611048478015784
P/E ratio: 33.04229218502123
Shares outstanding: 39186063
Book value: 56857046.22322435
P/B ratio: 3.177949755711629
Market cap (USD): 180688836.1555806
Debt to equity: 0.010128449680957802
Current ratio: 16.9079226686884
Quick ratio: 12.833017437452614
Effective tax rate (%): 26.139937106918236
Interest coverage ratio: 83.678391959799
COGS to revenue (%): 82.88609341874094
Buyback yield (%): 0
Inventory turnover: 1.698472501302374
Receivables turnover: 1.5951236114530682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.289426898551641
Revenue growth (%): -4.154881120520488
Rule of 40 score: -4.154881120520488
Financial ratios for JGCHEM.NS — quarterly report dated 2025-12-31
Total revenue: 27678623.148045003
Gross profit: 5111284.393449928
Operating income: 2389662.4707586053
Net income: 2045115.2946418626
Capital expenditures: 0
Owner earnings: 2045115.2946418626
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.9372841706583492
P/E ratio: 20.53452110251822
Shares outstanding: 39186063
Market cap (USD): 154286665.56032082
Effective tax rate (%): 25.093846907132367
Interest coverage ratio: 195.0181818181818
COGS to revenue (%): 81.53345863299944
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.454844274780923
Rule of 40 score: 11.454844274780923
Financial ratios for KRMD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3
Shares outstanding: 45933000
Market cap (USD): 137799000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KRMD — annual report dated 2022-12-31
Total revenue: 27896037
Gross profit: 15368986
Operating income: -10780873
Net income: -8661142
Capital expenditures: 2761056
Operating cash flow: -5404549
Depreciation & amortization: 587137
Net tangible assets: 30538781
Owner earnings: -10835061
Return on net tangible assets (%): -35.479677463222906
Buffett classification: The Gruesome
Stock price: 3.57
Shares outstanding: 45933000
Book value: 31325963
P/B ratio: 5.2346614212626115
Market cap (USD): 163980810
Debt to equity: 0.15721796006718133
Current ratio: 4.282496472163864
Quick ratio: 3.3621167879016056
COGS to revenue (%): 44.906202985033325
R&D to revenue (%): 17.76673511008033
SG&A to revenue (%): 73.86894059539712
Free cash flow (dilution-adjusted): -11285544
Buyback yield (%): 0
Retained earnings: -9571211
Inventory turnover: 1.9558643450363606
Receivables turnover: 6.156326027082855
Capitalized R&D asset: 4956215
ROCI (R&D-adjusted, %): -18.539008050258786
FCF margin (%): -40.455724947597396
Rule of 40 score: -40.455724947597396
Financial ratios for KRMD — annual report dated 2023-12-31
Total revenue: 28517666
Gross profit: 16708282
Operating income: -10269979
Net income: -13741062
Capital expenditures: 782949
Operating cash flow: -4892553
Depreciation & amortization: 870390
Net tangible assets: 19599410
Owner earnings: -13653621
Return on net tangible assets (%): -69.6634286440255
Buffett classification: The Gruesome
Stock price: 2.45
Shares outstanding: 45933000
Book value: 20353771
P/B ratio: 5.528992637285739
Market cap (USD): 112535850.00000001
Debt to equity: 0.21839294546450386
Current ratio: 4.547522404304356
Quick ratio: 3.7659589275747942
COGS to revenue (%): 41.41076622469735
R&D to revenue (%): 20.135778292655505
SG&A to revenue (%): 71.41403858225985
Free cash flow (dilution-adjusted): -8476020
Buyback yield (%): 0
Retained earnings: -23312273
Inventory turnover: 3.39223296118319
Receivables turnover: 6.99974620161508
Capitalized R&D asset: 9062918.05
ROCI (R&D-adjusted, %): -24.475283595996505
Rosenberg metric: 0.27022556527511415
FCF margin (%): -29.721997585636917
Revenue growth (%): 2.228377457342776
Rule of 40 score: -27.49362012829414
Financial ratios for KRMD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.73
Shares outstanding: 45933000
Market cap (USD): 125397090
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KRMD — annual report dated 2024-12-31
Total revenue: 33646463
Gross profit: 21331858
Operating income: -6446231
Net income: -6066633
Capital expenditures: 1288927
Operating cash flow: -319718
Depreciation & amortization: 888473
Net tangible assets: 16083400
Owner earnings: -6467087
Return on net tangible assets (%): -40.209700685178504
Buffett classification: The Gruesome
Stock price: 3.85
Shares outstanding: 45933000
Book value: 16813679
P/B ratio: 10.517748673565137
Market cap (USD): 176842050
Debt to equity: 0.23730755178566215
Current ratio: 2.65660763529219
Quick ratio: 2.2673075694754936
COGS to revenue (%): 36.599998638787085
R&D to revenue (%): 15.627027423357992
SG&A to revenue (%): 64.29107867890899
Free cash flow (dilution-adjusted): -4285180
Buyback yield (%): 0
Retained earnings: -29378906
Inventory turnover: 4.392317709401502
Receivables turnover: 5.6096670141746925
Capitalized R&D asset: 10740803.129999999
ROCI (R&D-adjusted, %): -21.156118222502084
Rosenberg metric: 0.8051848629475464
FCF margin (%): -12.735900353032651
Revenue growth (%): 17.984631000306965
Rule of 40 score: 5.248730647274314
Financial ratios for KRMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.85
Shares outstanding: 45933000
Market cap (USD): 176842050
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KRMD — quarterly report dated 2025-03-31
Total revenue: 9635075
Gross profit: 6046335
Operating income: -1245005
Net income: -1166237
Capital expenditures: 443438
Operating cash flow: -237467
Depreciation & amortization: 217357
Net tangible assets: 15628705
Owner earnings: -1392318
Return on net tangible assets (%): -8.908722763658282
Buffett classification: The Gruesome
Stock price: 2.54
Shares outstanding: 45933000
Book value: 16345031
P/B ratio: 7.137938129331171
Market cap (USD): 116669820
Debt to equity: 0.22825022479308849
Current ratio: 2.4359986188463365
Quick ratio: 2.01562042225196
COGS to revenue (%): 37.24662236671744
R&D to revenue (%): 11.568244149630386
SG&A to revenue (%): 61.85083146732122
Free cash flow (dilution-adjusted): -1381895
Buyback yield (%): 0
Retained earnings: -30545143
Inventory turnover: 1.0945798967012603
Receivables turnover: 1.5365529302083476
Capitalized R&D asset: 1114609
ROCI (R&D-adjusted, %): -2.4446940446644123
FCF margin (%): -14.342337760733571
Rule of 40 score: -14.342337760733571
Financial ratios for KRMD — quarterly report dated 2025-06-30
Total revenue: 10194800
Gross profit: 6475769
Operating income: -312655
Net income: -206867
Capital expenditures: 28814
Operating cash flow: -460340
Depreciation & amortization: 209487
Net tangible assets: 15827400
Owner earnings: -26194
Return on net tangible assets (%): -0.16549780759947938
Buffett classification: The Gruesome
Stock price: 3.58
Shares outstanding: 45933000
Book value: 16526374
P/B ratio: 9.9501645067454
Market cap (USD): 164440140
Debt to equity: 0.2097744490110172
Current ratio: 2.9053050072602282
Quick ratio: 2.2528524449929876
COGS to revenue (%): 36.47968572213286
R&D to revenue (%): 11.719592341193549
SG&A to revenue (%): 52.81268882175226
Free cash flow (dilution-adjusted): -904898
Buyback yield (%): 0
Retained earnings: -30752010
Inventory turnover: 0.942041261519265
Receivables turnover: 2.0028049642248207
Capitalized R&D asset: 1941577.03
ROCI (R&D-adjusted, %): 0.5247543455181418
Rosenberg metric: 0.38527770724980687
FCF margin (%): -8.876074076980421
Revenue growth (%): 5.809243830483935
Rule of 40 score: -3.066830246496486
Financial ratios for KRMD — quarterly report dated 2025-09-30
Total revenue: 10402163
Gross profit: 6264571
Operating income: -867679
Net income: -777966
Capital expenditures: 52483
Operating cash flow: 65456
Depreciation & amortization: 204482
Net tangible assets: 15783204
Owner earnings: -625967
Return on net tangible assets (%): -3.9660324988513107
Buffett classification: The Gruesome
Stock price: 3.83
Shares outstanding: 45933000
Book value: 16464825
P/B ratio: 10.684801690877372
Market cap (USD): 175923390
Debt to equity: 0.22310574208957581
Current ratio: 2.478869614900921
Quick ratio: 1.9157156329669442
COGS to revenue (%): 39.77626576318791
R&D to revenue (%): 8.970317038869705
SG&A to revenue (%): 57.62898543312578
Free cash flow (dilution-adjusted): -614420
Buyback yield (%): 0
Retained earnings: -31529976
Inventory turnover: 0.9378658162027875
Receivables turnover: 1.8861299095589315
Capitalized R&D asset: 2101436.6
ROCI (R&D-adjusted, %): -4.7513244401044465
Rosenberg metric: -0.17676593942528765
FCF margin (%): -5.906656144496101
Revenue growth (%): 2.0340075332522463
Rule of 40 score: -3.872648611243855
Financial ratios for KRMD — annual report dated 2025-12-31
Total revenue: 41127366
Gross profit: 25604079
Operating income: -2972442
Net income: -2637926
Capital expenditures: 925817
Operating cash flow: 462405
Depreciation & amortization: 810500
Net tangible assets: 16363081
Owner earnings: -2753243
Return on net tangible assets (%): -16.82594494276475
Buffett classification: The Gruesome
Stock price: 5.81
Shares outstanding: 45933000
Book value: 17047922
P/B ratio: 15.654150106974914
Market cap (USD): 266870729.99999997
Debt to equity: 0.20508423255338687
Current ratio: 2.439335699026086
Quick ratio: 1.9904742995119324
COGS to revenue (%): 37.74442301994249
R&D to revenue (%): 10.667383853369069
SG&A to revenue (%): 56.84489252241439
Free cash flow (dilution-adjusted): -3207624
Buyback yield (%): 0
Retained earnings: -32016832
Inventory turnover: 4.22042798366888
Receivables turnover: 6.298310006041436
Capitalized R&D asset: 9804978.96
ROCI (R&D-adjusted, %): -12.459795348164374
Rosenberg metric: 0.8125272207262841
FCF margin (%): -7.799244911526793
Revenue growth (%): 22.233846689918046
Rule of 40 score: 14.434601778391254
Financial ratios for KRMD — quarterly report dated 2025-12-31
Total revenue: 10895328
Gross profit: 6817403
Operating income: -547104
Net income: -486856
Capital expenditures: 401082
Operating cash flow: 1094756
Depreciation & amortization: 179174
Net tangible assets: 16363081
Owner earnings: -708764
Return on net tangible assets (%): -4.331482561260926
Buffett classification: The Gruesome
Stock price: 5.81
Shares outstanding: 45933000
Book value: 17047922
P/B ratio: 15.654150106974914
Market cap (USD): 266870729.99999997
Debt to equity: 0.20508423255338687
Current ratio: 2.439335699026086
Quick ratio: 1.9904742995119324
COGS to revenue (%): 37.42819858199771
R&D to revenue (%): 10.506420733731009
SG&A to revenue (%): 55.44233271361817
Free cash flow (dilution-adjusted): -306411
Buyback yield (%): 0
Retained earnings: -32016832
Inventory turnover: 1.1086948779148975
Receivables turnover: 1.6685277963461949
Capitalized R&D asset: 2164171.06
ROCI (R&D-adjusted, %): -2.2249143436695182
Rosenberg metric: 0.5924636724405669
FCF margin (%): -2.812315517256571
Revenue growth (%): 4.740985120113961
Rule of 40 score: 1.92866960285739
Financial ratios for KVHI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.19
Shares outstanding: 19497751
Market cap (USD): 179184331.69
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KVHI — annual report dated 2022-12-31
Total revenue: 138750000
Gross profit: 52498000
Operating income: -5725000
Net income: 24030000
Capital expenditures: 0
Operating cash flow: 8893000
Depreciation & amortization: 13408000
Net tangible assets: 152726000
Owner earnings: 37438000
Return on net tangible assets (%): 24.51318046698008
Buffett classification: The Gruesome
Stock price: 10.22
P/E ratio: 8.292426767374115
Shares outstanding: 19497751
Book value: 158438000
P/B ratio: 1.2576971131925423
Market cap (USD): 199267015.22
Debt to equity: 0.013683586008407075
Current ratio: 3.5006060606060605
Quick ratio: 2.8883501683501684
Interest coverage ratio: -1908.3333333333333
COGS to revenue (%): 62.163603603603605
R&D to revenue (%): 7.473153153153153
SG&A to revenue (%): 34.48936936936937
Free cash flow (dilution-adjusted): -8975000
Buyback yield (%): 0
Retained earnings: 13718000
Inventory turnover: 3.7946326440827103
Receivables turnover: 5.0588835818718785
Capitalized R&D asset: 10369000
ROCI (R&D-adjusted, %): 0.7006965667244844
FCF margin (%): -6.468468468468469
Rule of 40 score: -6.468468468468469
Financial ratios for KVHI — annual report dated 2023-12-31
Total revenue: 132379000
Gross profit: 37868000
Operating income: -11355000
Net income: -15422000
Capital expenditures: 0
Operating cash flow: 2530000
Depreciation & amortization: 13438000
Net tangible assets: 146178000
Owner earnings: -1984000
Return on net tangible assets (%): -1.3572493808917894
Buffett classification: The Gruesome
Stock price: 5.26
Shares outstanding: 19497751
Book value: 147372000
P/B ratio: 0.6959135402925929
Market cap (USD): 102558170.25999999
Debt to equity: 0.007294465705832858
Current ratio: 4.7580490148966845
Quick ratio: 3.9953547973730577
Interest coverage ratio: -11355
COGS to revenue (%): 71.39425437569403
R&D to revenue (%): 7.100068742021016
SG&A to revenue (%): 30.08332137272528
Free cash flow (dilution-adjusted): -11477000
Buyback yield (%): 0.23303847893746543
Retained earnings: -1704000
Inventory turnover: 4.962249291189751
Receivables turnover: 5.156953642384106
Capitalized R&D asset: 16346230
ROCI (R&D-adjusted, %): -5.21030763720414
Rosenberg metric: -1.4109364451731121
FCF margin (%): -8.669804123010447
Revenue growth (%): -4.591711711711712
Rule of 40 score: -13.26151583472216
Financial ratios for KVHI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.83
Shares outstanding: 19497751
Market cap (USD): 94174137.33
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KVHI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.7
Shares outstanding: 19497751
Market cap (USD): 111137180.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KVHI — annual report dated 2024-12-31
Total revenue: 113828000
Gross profit: 35219000
Operating income: -10746000
Net income: -11048000
Capital expenditures: 1403000
Operating cash flow: -13170000
Depreciation & amortization: 13298000
Net tangible assets: 137797000
Owner earnings: 847000
Buffett classification: The Gruesome
Stock price: 5.7
Shares outstanding: 19497751
Book value: 138625000
P/B ratio: 0.8017109518485123
Market cap (USD): 111137180.7
Debt to equity: 0.008865644724977457
Current ratio: 7.722719254032258
Quick ratio: 6.276587701612903
Interest coverage ratio: -5373
COGS to revenue (%): 69.0594581298099
R&D to revenue (%): 7.413817338440454
SG&A to revenue (%): 32.9672839723091
Free cash flow (dilution-adjusted): -22688000
Buyback yield (%): 0
Retained earnings: -12752000
Inventory turnover: 3.4247810743693634
Receivables turnover: 5.263965963743988
Capitalized R&D asset: 18158100
ROCI (R&D-adjusted, %): -7.440775952110279
Rosenberg metric: -0.2818384934567507
FCF margin (%): -19.93182696700285
Revenue growth (%): -14.013551998428753
Rule of 40 score: -33.9453789654316
Financial ratios for KVHI — quarterly report dated 2025-03-31
Total revenue: 25414000
Gross profit: 7439000
Operating income: -2243000
Net income: -1710000
Capital expenditures: 635000
Operating cash flow: -1277000
Depreciation & amortization: 2888000
Net tangible assets: 137078000
Owner earnings: 543000
Buffett classification: The Gruesome
Stock price: 5.29
Shares outstanding: 19497751
Book value: 137811000
P/B ratio: 0.7484388241141854
Market cap (USD): 103143102.79
Debt to equity: 0.007488516881816401
Current ratio: 9.311403844681013
Quick ratio: 7.627862449260933
COGS to revenue (%): 70.72873219485322
R&D to revenue (%): 4.670653970252617
SG&A to revenue (%): 33.426457857873615
Free cash flow (dilution-adjusted): -2806000
Buyback yield (%): 0.15803286462292004
Retained earnings: -14462000
Inventory turnover: 0.8177144936766445
Receivables turnover: 1.0955727033668148
Capitalized R&D asset: 1187000
ROCI (R&D-adjusted, %): -1.0401440677156477
FCF margin (%): -11.04115841662076
Rule of 40 score: -11.04115841662076
Financial ratios for KVHI — quarterly report dated 2025-06-30
Total revenue: 26623000
Gross profit: 9136000
Operating income: -370000
Net income: 930000
Capital expenditures: 5491000
Operating cash flow: 5096000
Depreciation & amortization: 2606000
Net tangible assets: 137748000
Owner earnings: -1955000
Return on net tangible assets (%): -1.4192583558381973
Buffett classification: The Gruesome
Stock price: 5.33
P/E ratio: 27.936293771505376
Shares outstanding: 19497751
Book value: 138384000
P/B ratio: 0.7509756390189617
Market cap (USD): 103923012.83
Debt to equity: 0.008765464215516244
Current ratio: 9.394974029941949
Quick ratio: 7.847616865261228
Effective tax rate (%): 10.144927536231885
COGS to revenue (%): 65.68380723434623
R&D to revenue (%): 3.4406340382376137
SG&A to revenue (%): 32.26533448521955
Free cash flow (dilution-adjusted): 2339000
Buyback yield (%): 1.0517401009033083
Retained earnings: -13532000
Inventory turnover: 0.8632145325303584
Receivables turnover: 1.050216962524655
Capitalized R&D asset: 1711290
ROCI (R&D-adjusted, %): -0.1101945687727503
Rosenberg metric: 1.429654591406908
FCF margin (%): 8.785636479735567
Revenue growth (%): 4.757220429684426
Rule of 40 score: 13.542856909419992
Financial ratios for KVHI — quarterly report dated 2025-09-30
Total revenue: 28453000
Gross profit: 1913000
Operating income: -7631000
Net income: -6934000
Capital expenditures: 8671000
Operating cash flow: 9896000
Depreciation & amortization: 2632000
Net tangible assets: 130510000
Owner earnings: -12973000
Return on net tangible assets (%): -9.940234464791969
Buffett classification: The Gruesome
Stock price: 5.6
Shares outstanding: 19497751
Book value: 131047000
P/B ratio: 0.8331927140644195
Market cap (USD): 109187405.6
Debt to equity: 0.03516295680175815
Current ratio: 7.8677533850400945
Quick ratio: 6.987380044695675
COGS to revenue (%): 93.27663163814009
R&D to revenue (%): 3.405616279478438
SG&A to revenue (%): 30.13741960425966
Free cash flow (dilution-adjusted): 8007000
Buyback yield (%): 0.1062393591665301
Retained earnings: -20466000
Inventory turnover: 1.9814842466776168
Receivables turnover: 1.1708089869146572
Capitalized R&D asset: 1974430
ROCI (R&D-adjusted, %): -5.608522911647959
Rosenberg metric: -7.885371179039302
FCF margin (%): 28.14114504621657
Revenue growth (%): 6.873755775081697
Rule of 40 score: 35.01490082129827
Financial ratios for KVHI — annual report dated 2025-12-31
Total revenue: 111009000
Gross profit: 28022000
Operating income: -11171000
Net income: -7383000
Capital expenditures: 15052000
Operating cash flow: 17108000
Depreciation & amortization: 10696000
Net tangible assets: 126535000
Owner earnings: -11739000
Return on net tangible assets (%): -9.277275062235745
Buffett classification: The Gruesome
Stock price: 6.97
Shares outstanding: 19497751
Book value: 130984000
P/B ratio: 1.0375261441855492
Market cap (USD): 135899324.47
Debt to equity: 0.03350027484272888
Current ratio: 7.066466706658669
Quick ratio: 6.175104979004199
COGS to revenue (%): 74.7570016845481
R&D to revenue (%): 3.114161914799701
SG&A to revenue (%): 32.191984433694564
Free cash flow (dilution-adjusted): 8152000
Buyback yield (%): 1.2825670817699835
Retained earnings: -20135000
Inventory turnover: 5.584965340870853
Receivables turnover: 4.431673919118528
Capitalized R&D asset: 12212800
ROCI (R&D-adjusted, %): -10.073484273513108
Rosenberg metric: -0.8528261642374689
FCF margin (%): 7.3435487212748525
Revenue growth (%): -2.476543556945567
Rule of 40 score: 4.867005164329285
Financial ratios for KVHI — quarterly report dated 2025-12-31
Total revenue: 30519000
Gross profit: 9534000
Operating income: -927000
Net income: 331000
Capital expenditures: 255000
Operating cash flow: 3393000
Depreciation & amortization: 2570000
Net tangible assets: 126535000
Owner earnings: 2646000
Return on net tangible assets (%): 2.0911210337060893
Buffett classification: The Gruesome
Stock price: 6.97
P/E ratio: 102.64299431268883
Shares outstanding: 19497751
Book value: 130984000
P/B ratio: 1.0375261441855492
Market cap (USD): 135899324.47
Debt to equity: 0.03350027484272888
Current ratio: 7.066466706658669
Quick ratio: 6.175104979004199
Effective tax rate (%): -512.9629629629629
COGS to revenue (%): 68.76044431337856
R&D to revenue (%): 1.2615092237622465
SG&A to revenue (%): 33.01549854189194
Free cash flow (dilution-adjusted): 612000
Buyback yield (%): 0.27299620615987596
Retained earnings: -20135000
Inventory turnover: 1.4122753886533415
Receivables turnover: 1.2183719908978403
Capitalized R&D asset: 1336510
ROCI (R&D-adjusted, %): -0.953734267454359
Rosenberg metric: 7.864809081527348
FCF margin (%): 2.005308168681805
Revenue growth (%): 7.261097248093347
Rule of 40 score: 9.266405416775152
Financial ratios for LAC.TO — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -119696.9696969697
Operating income: -21780303.030303027
Net income: -3854545.4545454546
Capital expenditures: 143139393.93939394
Operating cash flow: -29943939.39393939
Depreciation & amortization: 626515.1515151515
Net tangible assets: 291612878.78787875
Owner earnings: -146367424.24242425
Return on net tangible assets (%): -50.192373138942514
Buffett classification: The Gruesome
Stock price: 6.4393939393939394
Shares outstanding: 351062478
Book value: 291612878.7878788
P/B ratio: 7.752159652819091
Market cap (USD): 2260629593.181818
Debt to equity: 0.01011615129023794
Current ratio: 8.37365274331964
Quick ratio: 8.37365274331964
Interest coverage ratio: -76.25994694960211
Free cash flow (dilution-adjusted): -177311363.63636363
Buyback yield (%): 0
Retained earnings: -9965151.515151516
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.973010206061544
Rule of 40 score: 0
Financial ratios for LAC.TO — quarterly report dated 2024-09-30
Gross profit: -57777.777777777774
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.7037037037037033
Shares outstanding: 351062478
Market cap (USD): 949168921.9999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LAC.TO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -32167.83216783217
Operating income: -19788811.18881119
Net income: -29739860.139860142
Capital expenditures: 124260839.16083917
Operating cash flow: -9100000
Depreciation & amortization: 693706.2937062937
Net tangible assets: 444058741.25874126
Owner earnings: -153306993.00699303
Return on net tangible assets (%): -34.52403449427091
Buffett classification: The Gruesome
Stock price: 3.006993006993007
Shares outstanding: 351062478
Book value: 661076923.0769231
P/B ratio: 1.5968526195866035
Market cap (USD): 1055642416.3636364
Debt to equity: 0.023945881904923097
Current ratio: 10.33738846945779
Quick ratio: 10.33738846945779
Free cash flow (dilution-adjusted): -136973426.57342657
Buyback yield (%): 0
Retained earnings: -38938461.53846154
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.868048292022411
Rule of 40 score: 0
Financial ratios for LAC.TO — quarterly report dated 2024-12-31
Gross profit: 83216.78321678322
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.006993006993007
Shares outstanding: 351062478
Market cap (USD): 1055642416.3636364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LAC.TO — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -8391.608391608392
Operating income: -4570629.370629371
Net income: -7483916.083916084
Capital expenditures: 82470629.37062937
Operating cash flow: -13175524.475524476
Depreciation & amortization: 185314.6853146853
Net tangible assets: 437412587.4125874
Owner earnings: -89769230.76923077
Return on net tangible assets (%): -20.522781774580338
Buffett classification: The Gruesome
Stock price: 2.7202797202797204
Shares outstanding: 351062478
Book value: 653854545.4545455
P/B ratio: 1.4605513505922918
Market cap (USD): 954988139.4545455
Debt to equity: 0.022667088764636172
Current ratio: 10.348703302777649
Quick ratio: 10.348703302777649
Free cash flow (dilution-adjusted): -96368531.46853147
Buyback yield (%): 0
Retained earnings: -46422377.62237763
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6703039750584568
Rule of 40 score: 0
Financial ratios for LAC.TO — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -7299.2700729927
Operating income: -5728467.153284671
Net income: -9085401.459854014
Capital expenditures: 171948905.10948902
Operating cash flow: -22294160.583941605
Depreciation & amortization: 196350.36496350364
Net tangible assets: 449869343.0656934
Owner earnings: -180837956.20437953
Return on net tangible assets (%): -40.19788389491839
Buffett classification: The Gruesome
Stock price: 2.656934306569343
Shares outstanding: 351062478
Book value: 756083941.6058394
P/B ratio: 1.2336592410181157
Market cap (USD): 932749941.5474452
Debt to equity: 0.19953274411465144
Current ratio: 9.878286552642756
Quick ratio: 9.878286552642756
Free cash flow (dilution-adjusted): -195424817.51824814
Buyback yield (%): 0
Retained earnings: -57540875.912408754
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.609655204558431
Rule of 40 score: 0
Financial ratios for LAC.TO — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -6981294.964028778
Net income: -142218705.03597122
Capital expenditures: 123860431.65467627
Operating cash flow: 1664028.7769784173
Depreciation & amortization: 192805.75539568346
Net tangible assets: 342182733.81294966
Owner earnings: -265886330.93525183
Return on net tangible assets (%): -77.70302375355841
Buffett classification: The Gruesome
Stock price: 5.7194244604316555
Shares outstanding: 351062478
Book value: 644763309.3525181
P/B ratio: 3.114127765473025
Market cap (USD): 2007875323.81295
Debt to equity: 0.4522545220431121
Current ratio: 3.768833158772644
Quick ratio: 3.768833158772644
Free cash flow (dilution-adjusted): -123388489.20863311
Buyback yield (%): 0
Retained earnings: -198931654.676259
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7196624172173152
Rule of 40 score: 0
Financial ratios for LAC.TO — annual report dated 2025-12-31
Total revenue: 0
Operating income: -38570072.992700726
Net income: -62964963.50364963
Capital expenditures: 558426277.3722627
Operating cash flow: -44687591.24087591
Depreciation & amortization: 763503.6496350365
Net tangible assets: 772813138.6861314
Owner earnings: -620627737.2262774
Return on net tangible assets (%): -80.30760686618422
Buffett classification: The Gruesome
Stock price: 4.357664233576642
Shares outstanding: 351062478
Book value: 1158137956.2043796
P/B ratio: 1.3209241575546955
Market cap (USD): 1529812404.1313868
Debt to equity: 0.335425163347407
Current ratio: 5.155775114665279
Quick ratio: 5.155775114665279
Free cash flow (dilution-adjusted): -607643795.620438
Buyback yield (%): 0
Retained earnings: -161421897.81021896
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1996653940985644
Rule of 40 score: 0
Financial ratios for LAC.TO — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -20987591.24087591
Net income: 100491970.8029197
Capital expenditures: 174726277.37226275
Operating cash flow: -10329197.08029197
Depreciation & amortization: 178102.18978102188
Net tangible assets: 772813138.6861314
Owner earnings: -74056204.37956202
Return on net tangible assets (%): -9.582679262604907
Buffett classification: The Gruesome
Stock price: 4.357664233576642
P/E ratio: 3.805807548375147
Shares outstanding: 351062478
Book value: 1158137956.2043796
P/B ratio: 1.3209241575546955
Market cap (USD): 1529812404.1313868
Debt to equity: 0.335425163347407
Current ratio: 5.155775114665279
Quick ratio: 5.155775114665279
Free cash flow (dilution-adjusted): -186440145.98540145
Buyback yield (%): 0
Retained earnings: -161421897.81021896
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1969300179125306
Rule of 40 score: 0
Financial ratios for LGPS — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 23321928.8865125
Buffett classification: The Gruesome
Stock price: 2.86
Shares outstanding: 23610870
Book value: 23507679.45461835
P/B ratio: 2.872554406331823
Market cap (USD): 67527088.2
Debt to equity: 4.941220037762792
Current ratio: 2.083556244010419
Quick ratio: 0.35548653516259116
Buyback yield (%): 0
Retained earnings: 9339573.586418929
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LGPS — annual report dated 2025-03-31
Total revenue: 138022430.1563962
Gross profit: 23788731.453014303
Operating income: 8972837.855901618
Net income: 5036900.147039166
Capital expenditures: 250394.3323085149
Operating cash flow: 5377870.605534019
Depreciation & amortization: 963019.6497794412
Net tangible assets: 23321928.8865125
Owner earnings: 5749525.464510092
Return on net tangible assets (%): 24.6528728069107
Capex to operating income (%): 2.7905812668154417
Buffett classification: The Great
Stock price: 2.86
P/E ratio: 13.406477442220957
Shares outstanding: 23610870
Book value: 23507679.45461835
P/B ratio: 2.872554406331823
Market cap (USD): 67527088.2
Debt to equity: 4.941220037762792
Current ratio: 2.083556244010419
Quick ratio: 0.35548653516259116
Effective tax rate (%): 34.36752118887623
Interest coverage ratio: 6.3938162889160886
COGS to revenue (%): 82.76459020026036
SG&A to revenue (%): 10.734410037792028
Free cash flow (dilution-adjusted): 4996725.036759791
Buyback yield (%): 0
Retained earnings: 9339573.586418929
Inventory turnover: 1.2555950694025964
Receivables turnover: 143.28774232941535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.190929232605239
FCF margin (%): 3.620226821899813
Revenue growth (%): 48.012701056552416
Rule of 40 score: 51.63292787845223
Financial ratios for LGPS — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 26552113.055181697
Buffett classification: The Gruesome
Stock price: 1.05
Shares outstanding: 23610870
Book value: 26722698.51951547
P/B ratio: 0.9277286678923891
Market cap (USD): 24791413.5
Debt to equity: 4.603518062106885
Current ratio: 2.336645140533843
Quick ratio: 0.2850687882535015
Buyback yield (%): 0
Retained earnings: 12201231.493943473
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOVE — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 53.85
Shares outstanding: 14638418
Market cap (USD): 788278809.3000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOVE — annual report dated 2023-01-31
Total revenue: 651179000
Gross profit: 343651000
Operating income: 36966000
Net income: 26488000
Capital expenditures: 25242000
Operating cash flow: -21375000
Depreciation & amortization: 10842000
Net tangible assets: 191539000
Owner earnings: 12088000
Return on net tangible assets (%): 6.310986274335775
Capex to operating income (%): 68.28436942054861
Buffett classification: The Good
Stock price: 25.74
P/E ratio: 14.225040747508304
Shares outstanding: 14638418
Book value: 193094000
P/B ratio: 1.9513443158254529
Market cap (USD): 376792879.32
Debt to equity: 0.7590396387251804
Current ratio: 2.2880632854304555
Quick ratio: 0.8299265001645518
Effective tax rate (%): 28.117452305354284
Interest coverage ratio: 315.94871794871796
COGS to revenue (%): 47.226338687211964
SG&A to revenue (%): 45.43190121303052
Free cash flow (dilution-adjusted): -57374000
Buyback yield (%): 0
Retained earnings: 10540000
Inventory turnover: 2.5707240004346845
Receivables turnover: 71.53454904976381
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.31895218702635
FCF margin (%): -8.810787817174694
Rule of 40 score: -8.810787817174694
Financial ratios for LOVE — annual report dated 2024-01-31
Total revenue: 700265000
Gross profit: 401043000
Operating income: 30076000
Net income: 23861000
Capital expenditures: 28736000
Operating cash flow: 76441000
Depreciation & amortization: 12603000
Net tangible assets: 215895000
Owner earnings: 7728000
Return on net tangible assets (%): 3.5795178211630656
Capex to operating income (%): 95.54462029525203
Buffett classification: The Gruesome
Stock price: 23.16
P/E ratio: 14.208363475126776
Shares outstanding: 14638418
Book value: 217496000
P/B ratio: 1.558767797476735
Market cap (USD): 339025760.88
Debt to equity: 0.8069297826166918
Current ratio: 2.0163225393959907
Quick ratio: 1.0907518146601978
Effective tax rate (%): 25.019639883103416
COGS to revenue (%): 42.72982370959566
SG&A to revenue (%): 51.17548356693538
Free cash flow (dilution-adjusted): 43014000
Buyback yield (%): 0
Retained earnings: 34401000
Inventory turnover: 3.039638358390898
Receivables turnover: 52.01403847582262
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.002682106517945
FCF margin (%): 6.142531755835291
Revenue growth (%): 7.538019500014589
Rule of 40 score: 13.680551255849881
Financial ratios for LOVE — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.16
Shares outstanding: 14638418
Market cap (USD): 426856268.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOVE — quarterly report dated 2025-01-31
Total revenue: 241490000
Gross profit: 145782000
Operating income: 47598000
Net income: 35307000
Capital expenditures: 5287000
Operating cash flow: 44023000
Depreciation & amortization: 3786000
Net tangible assets: 214625000
Owner earnings: 33806000
Return on net tangible assets (%): 15.751193942923706
Capex to operating income (%): 11.107609563427035
Buffett classification: The Great
Stock price: 25.56
P/E ratio: 2.649318577619169
Shares outstanding: 14638418
Book value: 216355000
P/B ratio: 1.7293705441519722
Market cap (USD): 374157964.08
Debt to equity: 0.8459383882970118
Current ratio: 1.5898201276513442
Quick ratio: 0.7882406034427181
Effective tax rate (%): 26.840033153750518
COGS to revenue (%): 39.63228291026544
SG&A to revenue (%): 39.0898173837426
Free cash flow (dilution-adjusted): 37326000
Buyback yield (%): 4.409367589051908
Retained earnings: 25845000
Inventory turnover: 0.769771500727884
Receivables turnover: 14.390679935641499
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.620777430132046
FCF margin (%): 15.456540643504907
Rule of 40 score: 15.456540643504907
Financial ratios for LOVE — annual report dated 2025-01-31
Total revenue: 680628000
Gross profit: 397835000
Operating income: 13648000
Net income: 11556000
Capital expenditures: 21026000
Operating cash flow: 38977000
Depreciation & amortization: 14710000
Net tangible assets: 214625000
Owner earnings: 5240000
Return on net tangible assets (%): 2.4414676761793825
Capex to operating income (%): 154.05920281359906
Buffett classification: The Gruesome
Stock price: 25.56
P/E ratio: 32.37780928348909
Shares outstanding: 14638418
Book value: 216355000
P/B ratio: 1.7293705441519722
Market cap (USD): 374157964.08
Debt to equity: 0.8459383882970118
Current ratio: 1.5898201276513442
Quick ratio: 0.7882406034427181
Effective tax rate (%): 29.74648914827649
COGS to revenue (%): 41.54883431184142
SG&A to revenue (%): 54.28471940619546
Free cash flow (dilution-adjusted): 9515000
Buyback yield (%): 5.326359963766243
Retained earnings: 25845000
Inventory turnover: 2.274480628634393
Receivables turnover: 40.55944222632739
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.618815294055258
FCF margin (%): 1.3979736361125312
Revenue growth (%): -2.8042241151564054
Rule of 40 score: -1.4062504790438741
Financial ratios for LOVE — quarterly report dated 2025-04-30
Total revenue: 138373000
Gross profit: 74370000
Operating income: -14954000
Net income: -10840000
Capital expenditures: 8577000
Operating cash flow: -41377000
Depreciation & amortization: 3613000
Net tangible assets: 199351000
Owner earnings: -15804000
Return on net tangible assets (%): -7.927725469147383
Buffett classification: The Gruesome
Stock price: 19.45
Shares outstanding: 14638418
Book value: 201214000
P/B ratio: 1.4149971179937777
Market cap (USD): 284717230.09999996
Debt to equity: 0.9523989384436471
Current ratio: 1.6048556140273293
Quick ratio: 0.4999513554150268
COGS to revenue (%): 46.25396573030866
SG&A to revenue (%): 61.94199735497532
Free cash flow (dilution-adjusted): -52579000
Buyback yield (%): 2.107354022056427
Retained earnings: 8947000
Inventory turnover: 0.5123272977602741
Receivables turnover: 10.626094301950545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.034261819653335
FCF margin (%): -37.99801984491194
Revenue growth (%): -42.70031885378277
Rule of 40 score: -80.6983386986947
Financial ratios for LOVE — quarterly report dated 2025-07-31
Total revenue: 160530000
Gross profit: 90608000
Operating income: -8823000
Net income: -6650000
Capital expenditures: 4333000
Operating cash flow: 12165000
Depreciation & amortization: 3836000
Net tangible assets: 195455000
Owner earnings: -7147000
Return on net tangible assets (%): -3.65659614745082
Buffett classification: The Gruesome
Stock price: 18.01
P/E ratio: 14.796986483695349
Shares outstanding: 14638418
Book value: 197461000
P/B ratio: 1.3351391321830641
Market cap (USD): 263637908.18000004
Debt to equity: 0.9797681567499404
Current ratio: 1.516960597076944
Quick ratio: 0.526229992888136
COGS to revenue (%): 43.55696754500716
SG&A to revenue (%): 59.54961689403849
Free cash flow (dilution-adjusted): 4404000
Buyback yield (%): 0
Retained earnings: 2307000
Inventory turnover: 0.5639644144761782
Receivables turnover: 11.407760090960773
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3938724678890617
FCF margin (%): 2.743412446271725
Revenue growth (%): 16.01251689274642
Rule of 40 score: 18.755929339018145
Financial ratios for LOVE — quarterly report dated 2025-10-31
Total revenue: 150166000
Gross profit: 84237000
Operating income: -15804000
Net income: -10551000
Capital expenditures: 5301000
Operating cash flow: -4881000
Depreciation & amortization: 4002000
Net tangible assets: 187059000
Owner earnings: -11850000
Return on net tangible assets (%): -6.334899684056902
Buffett classification: The Gruesome
Stock price: 13.87
P/E ratio: 27.943140333058075
Shares outstanding: 14638418
Book value: 189307000
P/B ratio: 1.0725163763622052
Market cap (USD): 203034857.66
Debt to equity: 1.0116635940562155
Current ratio: 1.3575818625089418
Quick ratio: 0.41099140133432605
COGS to revenue (%): 43.90407948536952
SG&A to revenue (%): 63.95522288667208
Free cash flow (dilution-adjusted): -12864000
Buyback yield (%): 0
Retained earnings: -8242000
Inventory turnover: 0.5083936737070195
Receivables turnover: 8.854127358490565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.408171462361513
FCF margin (%): -8.566519718178549
Revenue growth (%): -6.4561141219709715
Rule of 40 score: -15.02263384014952
Financial ratios for LOVE — quarterly report dated 2026-01-31
Total revenue: 248046000
Gross profit: 144000000
Operating income: 44944000
Net income: 32106000
Capital expenditures: 4924000
Operating cash flow: 83421000
Depreciation & amortization: 3755000
Net tangible assets: 216190000
Owner earnings: 30937000
Return on net tangible assets (%): 14.310097599333918
Capex to operating income (%): 10.955856176575294
Buffett classification: The Great
Stock price: 13.32
P/E ratio: 47.966476693726946
Shares outstanding: 14638418
Book value: 218707000
P/B ratio: 0.8915294332600237
Market cap (USD): 194983727.76
Debt to equity: 0.8802233124682795
Current ratio: 1.6085540850106381
Quick ratio: 0.8858548986819477
Effective tax rate (%): 29.61525813877014
COGS to revenue (%): 41.94625190488861
SG&A to revenue (%): 38.420696161195906
Free cash flow (dilution-adjusted): 80837000
Buyback yield (%): 0
Retained earnings: 23864000
Inventory turnover: 0.9786393521261887
Receivables turnover: 21.140884684223984
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.596326866561224
FCF margin (%): 32.58951968586472
Revenue growth (%): 65.18119947258367
Rule of 40 score: 97.7707191584484
Financial ratios for LOVE — annual report dated 2026-01-31
Total revenue: 697115000
Gross profit: 393215000
Operating income: 5363000
Net income: 4065000
Capital expenditures: 23135000
Operating cash flow: 49328000
Depreciation & amortization: 15206000
Net tangible assets: 216190000
Owner earnings: -3864000
Return on net tangible assets (%): -1.7873167121513482
Capex to operating income (%): 431.3816893529741
Buffett classification: The Gruesome
Stock price: 13.32
P/E ratio: 47.966476693726946
Shares outstanding: 14638418
Book value: 218707000
P/B ratio: 0.8915294332600237
Market cap (USD): 194983727.76
Debt to equity: 0.8802233124682795
Current ratio: 1.6085540850106381
Quick ratio: 0.8858548986819477
Effective tax rate (%): 39.00975243810953
COGS to revenue (%): 43.593955086320044
SG&A to revenue (%): 53.45545569956176
Free cash flow (dilution-adjusted): 19798000
Buyback yield (%): 3.0771798595343465
Retained earnings: 23864000
Inventory turnover: 2.858432800022574
Receivables turnover: 59.41489815051564
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3837464619385869
FCF margin (%): 2.8399905324085695
Revenue growth (%): 2.422321738159465
Rule of 40 score: 5.262312270568034